Health Claim For Anxiety Reduction Among Latest EU Rejections
Executive Summary
The health claim “Affron contributes to maintain a healthy mood by reducing the negative traits of depressive and anxiety feelings” is one of four rejected by the European Commission in the first half of 2023.
You may also be interested in...
EU Authorizes Cholesterol Lowering Health Claim For Supplement After 10 Year Wait
France's Laboratoire Lescuyer can now claim its Limicol botanical extract supplement "reduces blood LDL-cholesterol concentrations" after waiting more than 10 years for approval by the European Commission.
EU Rejects 8 Health Claims For Foods In 2022, Authorizes None
Five general function health claims, two for the reduction of disease risk and one for children's development or health were rejected by the European Commission in 2022 after applicants failed to establish a cause and effect relationship between the food and the claimed effect.
Euro Q1 Consumer Health Earnings Preview: Reckitt, Sanofi, Haleon, Bayer
Major Europe-based consumer health players Reckitt, Sanofi, Haleon and Bayer feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q1 2024 results over the coming weeks.